385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Conventional release cutaneous paste	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous foam	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous spray	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release solution for cutaneous spray	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cutaneous liquid	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous solution	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous suspension	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous emulsion	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous powder	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Prolonged-release transdermal patch	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous stick	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous sponge	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release powder for cutaneous spray	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release suspension for cutaneous spray	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Bath additive	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cream	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous liniment	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cutaneous aerosol	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Prolonged-release transdermal drug delivery system	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tablet for conventional release cutaneous solution	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Powder for conventional release cutaneous solution	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous cream	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous gel	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conventional release cutaneous oil	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Shampoo dose form	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Medicated nail laquer	Is a	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely hydrocortisone 2 milligram/1 gram and lidocaine hydrochloride 10 milligram/1 gram conventional release cutaneous spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely benzydamine hydrochloride 30 milligram/1 gram conventional release cutaneous cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely felbinac 31.7 milligram/1 gram conventional release transdermal foam	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely felbinac 30 milligram/1 gram conventional release transdermal gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 milliliter conventional release cutaneous spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous foam	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ibuprofen 100 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely fluticasone propionate 50 microgram/1 gram conventional release cutaneous ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely coal tar 60 milligram/1 milliliter and lecithin 4 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Erythromycin 3% in benzoyl peroxide topical gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Minoxidil 20mg/mL topical liquid	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Minoxidil 50mg/mL topical liquid	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Surgical spirit BP	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate+ethyl alcohol 1%/61% solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Industrial methylated spirit BP 95%(66OP)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Industrial methylated spirit BP 99%(74OP)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Isopropyl alcohol 70% BP	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 0.5% in 70% IMS hand rub	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 0.5% in 70% IMS spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 0.02% in 70% IMS spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate pink 0.5% in 70% IMS spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Industrial methylated spirit 70% spray	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Industrial methylated spirit 70% spray refill	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 0.5% in 70% IMS solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate blue 0.5% in 70% IMS solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate pink 0.5% in 70% IMS solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 0.5% in 70% IMS surgical scrub	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing erythromycin in topical dosage form	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 2%/isopropyl alcohol 70% topical sponge	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely eflornithine (as eflornithine monohydrate chloride) 115 milligram/1 gram conventional release cutaneous cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely fentanyl 12 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely diclofenac sodium 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely diclofenac sodium 30 milligram/1 gram conventional release cutaneous gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely cinchocaine 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely cinchocaine 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocaine hydrochloride 4% topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocaine hydrochloride 10% topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocaine viscous 10% topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocaine viscous 4% topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ciclopirox olamine 1% gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ciclopirox olamine 1% lotion	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ciclopirox olamine 8% solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eflornithine hydrochloride 13.9% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ciclopirox olamine 1% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ciclopirox 0.77% gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ciclopirox 0.77% lotion	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ciclopirox 0.77% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Erythromycin 20mg/mL	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely erythromycin 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 2.17mg	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoyl peroxide + erythromycin 50mg/30mg gel	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Page 1 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module